Zinzino reported its sales results for July 2026. Revenue in July increased by 20% year-over-year to $33 million. Faun Pharma grew 14% year-over-year.
All markets, with the exception of the Nordics, East Europe, the Baltics showed growth, including: Central Europe (Austria, Germany and Switzerland), South and West Europe (Cyprus, France, Greece, Italy, Luxembourg, Malta and Netherlands), North America (Canada, US, Mexico), South America (Peru, Colombia), Asia-Pacific (Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines and South Korea) and Africa (South Africa) which showed significant positive growth compared to the second quarter of 2026.
Overall group revenue increased 20% year-over-year to $33.2 million.
